Charles Schwab Investment Management Inc Bridge Bio Pharma, Inc. Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,189,197 shares of BBIO stock, worth $29.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,189,197

Previous 1,048,037 13.47%

Holding current value

$29.7 Million

Previous $32.4 Million 7.05%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$23.0 - $31.04 $3.25 Million - $4.38 Million	141,160 Added 13.47%	1,189,197 $30.1 Million
Q1 2024 May 08, 2024	SELL	$27.35 - $40.45 $2.06 Million - $3.04 Million	-75,183 Reduced 6.69%	1,048,037 $32.4 Million
Q4 2023 Feb 06, 2024	BUY	$24.02 - $43.89 $1.61 Million - $2.94 Million	66,945 Added 6.34%	1,123,220 $45.3 Million
Q3 2023 Nov 08, 2023	BUY	$16.89 - $35.01 $1.58 Million - $3.27 Million	93,324 Added 9.69%	1,056,275 $27.9 Million
Q2 2023 Aug 09, 2023	BUY	$13.29 - $18.01 $506,734 - $686,703	38,129 Added 4.12%	962,951 $16.6 Million
Q1 2023 May 11, 2023	BUY	$7.17 - $18.55 $922,800 - $2.39 Million	128,703 Added 16.17%	924,822 $15.3 Million
Q4 2022 Feb 13, 2023	BUY	$6.74 - $11.52 $164,880 - $281,813	24,463 Added 3.17%	796,119 $6.07 Million
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $2.37 Million - $3.69 Million	-298,503 Reduced 27.89%	771,656 $7.67 Million
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $46,488 - $108,325	-8,923 Reduced 0.83%	1,070,159 $9.72 Million
Q1 2022 May 13, 2022	BUY	$7.34 - $17.16 $248,033 - $579,870	33,792 Added 3.23%	1,079,082 $11 Million
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $25,058 - $117,608	-2,202 Reduced 0.21%	1,045,290 $17.4 Million
Q3 2021 Nov 16, 2021	BUY	$46.87 - $64.24 $15 Million - $20.6 Million	320,410 Added 44.07%	1,047,492 $49.1 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $1.74 Million - $2.4 Million	37,550 Added 5.45%	727,082 $44.3 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $8.94 Million - $11.7 Million	161,089 Added 30.48%	689,532 $42.5 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $226,442 - $419,549	5,900 Added 1.13%	528,443 $37.6 Million
Q3 2020 Nov 13, 2020	BUY	$27.2 - $42.19 $7.18 Million - $11.1 Million	264,132 Added 102.21%	522,543 $19.6 Million
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $82,058 - $131,803	3,693 Added 1.45%	258,411 $8.43 Million
Q1 2020 May 15, 2020	BUY	$16.11 - $36.23 $1.96 Million - $4.41 Million	121,687 Added 91.47%	254,718 $7.39 Million
Q4 2019 Feb 07, 2020	BUY	$17.96 - $46.63 $121,912 - $316,524	6,788 Added 5.38%	133,031 $4.66 Million
Q3 2019 Nov 08, 2019	BUY	$20.13 - $32.38 $2.54 Million - $4.09 Million	126,243 New	126,243 $2.71 Million

Others Institutions Holding BBIO

# of Institutions

292

Shares Held

175M

Call Options Held

8.66M

Put Options Held

2.76M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.7B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Bridge Bio Pharma, Inc. Transaction History